Health, Fitness & Food

The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix‘s treatment for seizures associated with Dravet syndrome, a rare form of childhood epilepsy, the company said. As part of a preliminary review, FDA determined that the application was not sufficient enough for a substantive review. Shares of Zogenix
0 Comments
Several U.S. states sued the Trump administration on Wednesday to undo its recent decision that allowed fewer whole grains and more sodium in school breakfasts and lunches. The states accused the U.S. Department of Agriculture of ignoring federal dietary guidelines and scientific research on children’s nutrition when it eased rules championed by former first lady
0 Comments